banner
DPP-4 inhibitor Teneligliptin hydrobromide, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ809

DPP-4 inhibitor Teneligliptin hydrobromide, Purity ≥98%

Synonym: 906093-29-6; DPP-4 inhibitor

  • MDL: MFCD23098790
  • CAS Number: 906093-29-6
  • Compound CID: 11996485
img
Product Size
100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Teneligliptin hydrobromide, soluble in DMSO, water and ethanol, prolongs the action of incretin hormones, thereby improving blood glucose control. It targets Dipeptidyl peptidase-4, DPP-8, DPP-9, and FAP.
Molecular Weight
1257.72
Molecular Formula
C44H65Br5N12O2S2
Targets
Dipeptidyl peptidase-4: 1.75 nM; DPP-8: 189 nM; DPP-9: 150 nM; FAP: >10 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 85 mg/mL (135.16 mM); Water: 85 mg/mL (135.16 mM); Ethanol: 14 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Teneligliptin hydrobromide is employed in research to understand glucose metabolism and diabetic therapy by inhibiting the enzyme DPP-4, which effectively increases insulin secretion.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0